Teleflex Inc. (TFX)

277.32
NYSE : Health Technology
Prev Close 277.32
Day Low/High 0.00 / 0.00
52 Wk Low/High 197.72 / 288.78
Avg Volume 287.10K
Exchange NYSE
Shares Outstanding 45.54M
Market Cap 12.59B
EPS 3.40
P/E Ratio 75.92
Div & Yield 1.36 (0.49%)

Latest News

NeoTract Announces Sponsorship Of Fifth Annual Drive For Men's Health

NeoTract Announces Sponsorship Of Fifth Annual Drive For Men's Health

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced its sponsorship of the fifth annual "Drive for Men's Health" event.

NeoTract Announces American Urological Association (AUA) Recommendation Of UroLift® System As A Standard Of Care Option For The Treatment Of Enlarged Prostate

NeoTract Announces American Urological Association (AUA) Recommendation Of UroLift® System As A Standard Of Care Option For The Treatment Of Enlarged Prostate

NeoTract, a wholly owned subsidiary of  Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in the field of urology, today announced that the American Urological Association (AUA) has recommended the use of the UroLift ® System as a...

Teleflex To Introduce The New TrapLiner® Catheter In Europe And Showcase The Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) At The European Association For Percutaneous Cardiovascular Interventions Course (EuroPCR) 2018

Teleflex To Introduce The New TrapLiner® Catheter In Europe And Showcase The Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) At The European Association For Percutaneous Cardiovascular Interventions Course (EuroPCR) 2018

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will showcase its complex PCI product portfolio and the Arrow ® AC3 Optimus™ Intra-Aortic...

NeoTract To Unveil New Clinical Data On The UroLift® System At American Urological Association 2018 Meeting

NeoTract To Unveil New Clinical Data On The UroLift® System At American Urological Association 2018 Meeting

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced a series of presentations planned for the 113th Annual Meeting of the American Urological Association (AUA)...

Teleflex Incorporated Hosts Analyst & Investor Day

Teleflex Incorporated Hosts Analyst & Investor Day

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, will provide an update on its business and address its 3-year business growth strategy and financial goals during its 2018 Analyst & Investor Day today in New York City.

Teleflex Announces Quarterly Dividend

Teleflex Announces Quarterly Dividend

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATVI, BGCP, HSC, LIND, PE, QTWO, TFX, WTI, WTS Downgrades: ADM, BLL, CAH, CENX, DRH, FLR, GLT, GPN, IMOS, ITGR, JCAP, LND, NEWM, NFG, PXLW, SBGI, SEE, SHEN, STC Initiations: AKBA, BTU Read on to get TheStreet Quant Ratings' detailed report:

Teleflex Reports First Quarter 2018 Results

Teleflex Reports First Quarter 2018 Results

Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the first quarter ended April 1, 2018.

Teleflex To Present At The Bank Of America Merrill Lynch Health Care Conference 2018

Teleflex To Present At The Bank Of America Merrill Lynch Health Care Conference 2018

Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch Health Care Conference at the Encore at the Wynn, Las Vegas, Nevada, on Tuesday, May 15, 2018 at 3:00 p.

Teleflex Incorporated To Host Analyst & Investor Day On May 11, 2018

Teleflex Incorporated To Host Analyst & Investor Day On May 11, 2018

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, today announced the agenda for its 2018 Analyst & Investor Day, which will be held on Friday, May 11, 2018.

Teleflex Announces First Quarter 2018 Earnings Conference Call Information

Teleflex Announces First Quarter 2018 Earnings Conference Call Information

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2018 will be released before market open on Thursday, May 3, 2018.

NeoTract Announces Data From Large Real-World Study Of UroLift® System, Confirming Positive Results For Company's Treatment For Enlarged Prostate

NeoTract Announces Data From Large Real-World Study Of UroLift® System, Confirming Positive Results For Company's Treatment For Enlarged Prostate

NeoTract, a wholly owned subsidiary of  Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced the results from the first analysis of a retrospective registry of...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACIW, AMC, CTRP, GSIT, ITGR, JNP, KFFB, MD, MDSO, NJR, VECO Downgrades: NEM, TFX, TTEC Initiations: CNAT, OTEL Read on to get TheStreet Quant Ratings' detailed report:

Teleflex To Present At Needham & Company's 17th Annual Healthcare Conference

Teleflex To Present At Needham & Company's 17th Annual Healthcare Conference

Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at Needham & Company's 17 th Annual Healthcare Conference at the Westin Grand Central Hotel in New York, NY on Tuesday, March 27,...

Teleflex To Present At The 28th Annual Oppenheimer Healthcare Conference

Teleflex To Present At The 28th Annual Oppenheimer Healthcare Conference

Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 28 th Annual Oppenheimer Healthcare Conference at the Westin Grand Central Hotel in New York, NY on Tuesday, March 20, 2018 at...

Teleflex To Present At Barclays Global Healthcare Conference

Teleflex To Present At Barclays Global Healthcare Conference

Liam Kelly, President and Chief Executive Officer, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami, Florida, on Tuesday, March 13,...

Teleflex Announces Quarterly Dividend

Teleflex Announces Quarterly Dividend

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.

Teleflex Reports Fourth Quarter And Full Year 2017 Results; Provides 2018 Guidance

Teleflex Reports Fourth Quarter And Full Year 2017 Results; Provides 2018 Guidance

Teleflex Incorporated (NYSE: TFX) (the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2017.

Teleflex Highlights LMA® Gastro™ Airway Study, Which Shows Efficacy For Use In Upper Gastrointestinal Endoscopy

Teleflex Highlights LMA® Gastro™ Airway Study, Which Shows Efficacy For Use In Upper Gastrointestinal Endoscopy

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, has announced that newly published research, in the February 2018 edition of the British Journal of Anesthesia, affirms the LMA®...

Teleflex To Present At The Raymond James 39th Annual Institutional Investors Conference

Teleflex To Present At The Raymond James 39th Annual Institutional Investors Conference

Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 39 th Annual Institutional Investors Conference at the J.

NeoTract Announces FDA Clearance Of Expanded Indications For UroLift® System

NeoTract Announces FDA Clearance Of Expanded Indications For UroLift® System

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in the field of urology, today announced that the U.

Impact Of Common Men's Health Condition Extends To Other Side Of The Bed

Impact Of Common Men's Health Condition Extends To Other Side Of The Bed

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced that a common health problem that affects nearly 40 million men in the United States often...

Teleflex Announces Fourth Quarter And Full Year 2017 Earnings Conference Call Information

Teleflex Announces Fourth Quarter And Full Year 2017 Earnings Conference Call Information

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2017 will be released before market open on Thursday, February 22, 2018.

Teleflex Announces U.S. Launch Of Two Next-Generation Versions Of Its 0.035" Snares For Peripheral Procedures

Teleflex Announces U.S. Launch Of Two Next-Generation Versions Of Its 0.035" Snares For Peripheral Procedures

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance by the Food and Drug Administration and U.

Teleflex Surpasses 200,000 Successfully Reprocessed ClosureFast® Catheters

Teleflex Surpasses 200,000 Successfully Reprocessed ClosureFast® Catheters

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast ® Catheters have been successfully reprocessed by...

Teleflex Completes Previously Announced CEO Transition

Teleflex Completes Previously Announced CEO Transition

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, announced today that it has completed its previously announced senior leadership transition.

TheStreet Quant Rating: B (Buy)